Similar articles

• Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.

  Zahavi M, Zahavi J, Kakkar VV. Zahavi M, et al. Thromb Haemost. 1984 Oct 31;52(2):205-9. Thromb Haemost. 1984. PMID: 6098048
• Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors.

  Asano T, Ochiai Y, Hidaka H. Asano T, et al. Mol Pharmacol. 1977 May;13(3):400-6. Mol Pharmacol. 1977. PMID: 195193 No abstract available.
• Roles of cyclic nucleotides in platelet function.

  Haslam RJ. Haslam RJ. Ciba Found Symp. 1975;35:121-51. doi: 10.1002/9780470720172.ch7. Ciba Found Symp. 1975. PMID: 179765 No abstract available.
• Regulation of blood platelet function by cyclic nucleotides.

  Haslam RJ, Davidson MM, Davies T, Lynham JA, McClenaghan MD. Haslam RJ, et al. Adv Cyclic Nucleotide Res. 1978;9:533-52. Adv Cyclic Nucleotide Res. 1978. PMID: 208396 Review. No abstract available.
• Cyclic nucleotides in hemostasis and thrombosis.

  Steer ML, Salzman EW. Steer ML, et al. Adv Cyclic Nucleotide Res. 1980;12:71-92. Adv Cyclic Nucleotide Res. 1980. PMID: 6250376 Review. No abstract available.